Rafael Bejar serves as Executive at Aptose Biosciences Inc., where they oversee executive responsibilities. Since joining the company, Rafael Bejar has executed 2 insider transactions totaling $25.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 19, 2023 involved receiving (via award) 100,000 shares valued at $0.
Rafael Bejar currently holds 110,000 shares of Aptose Biosciences Inc. (APTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rafael Bejar has been a net buyer of APTO stock. They have purchased $25.6K and sold $0 worth of shares.
Rafael Bejar's most recent insider trade was on Jan 19, 2023, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.56 |
| Discretionary |